Cancer Cells Gain Survival Advantage by Blocking Proautophagic MicroRNA

Normally miR-101 targets a group of genes including, STMN1, RAB5A and ATG4D. siRNA-mediated depletion of these genes caused an effect identical to miR-101 overexpression, demonstrating their importance in autophagy regulation.

Overexpression of STMN1 could partially rescue cancer cells from miR-101-mediated inhibition of autophagy. Breast cancer cells where miR-101-mediated inhibition of autophagy was active were more sensitive to 4-hydroxytamoxifen (4-OHT)-mediated cell death than were cells where miR-101 was blocked.

"We have discovered a small molecule that can block autophagy in different cancer cells and specifically, this molecule can increase the sensitivity of breast cancer cells towards one of the most commonly used treatments for breast cancer," said senior author Dr. Anders H. Lund, professor at the Biotech Research and Innovation Center of the University of Copenhagen. "This result has a clear clinical relevance, as resistance against tamoxifen is a large problem in the treatment of breast cancer."

Related Links:
Biotech Research and Innovation Center of the University of Copenhagen